Comparison between Satol Chemicals IPO and Studio LSD IPO.
Satol Chemicals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Studio LSD IPO is a SME Bookbuilding proposed to list at NSE SME.
Satol Chemicals IPO | Studio LSD IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price | Bookbuilding |
Listing At | BSE SME | NSE SME |
Lead Managers | Finshore Management Services Ltd. | Corpwis Advisors Pvt.Ltd. |
Registrar | Kfin Technologies Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
Market Maker | Rikhav Securities Ltd. | |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of Satol Chemicals IPO is up to ₹30.24 Cr whereas the issue size of the Studio LSD IPO is up to ₹70.53 Cr. The final issue price of Satol Chemicals IPO is ₹72.00 per share and of Studio LSD IPO is ₹54.00 per share.
Satol Chemicals IPO | Studio LSD IPO | |
---|---|---|
Face Value | ₹10 per share | ₹2 per share |
Issue Price (Lower) | ₹51.00 per share | |
Issue Price (Upper) | ₹54.00 per share | |
Issue Price (Final) | ₹72.00 per share | ₹54.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 2000 shares |
Fresh Issue Size | 42,00,000 shares | 1,03,12,000 shares |
Fresh Issue Size (Amount) | up to ₹30.24 Cr | up to ₹55.68 Cr |
OFS Issue Size | 0 shares | 27,50,000 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹14.85 Cr |
Issue Size Total | 42,00,000 shares | 1,30,62,000 shares |
Issue Size Total (Amount) | up to ₹30.24 Cr | up to ₹70.53 Cr |
Satol Chemicals IPO opens on , while Studio LSD IPO opens on Aug 18, 2025. The closing date of Satol Chemicals IPO and Studio LSD IPO is , and Aug 20, 2025, respectively.
Satol Chemicals IPO | Studio LSD IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 18, 2025 | |
Issue Close | Aug 20, 2025 | |
Basis Of Allotment (Tentative) | Aug 21, 2025 | |
Initiation of Refunds (Tentative) | Aug 22, 2025 | |
Credit of Share (Tentative) | Aug 22, 2025 | |
Listing date (Tentative) | Aug 25, 2025 | |
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Satol Chemicals IPO P/E ratio is 14.55, as compared to Studio LSD IPO P/E ratio of 18.92.
Satol Chemicals IPO | Studio LSD IPO | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Satol Chemicals Limited Financial Information (Restated Standalone)
| EBITDA | ||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.98 | 100.00 | ||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 72.63 | 73.50 | ||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 14.55 | 18.92 | ||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹110.56 Cr. | ₹280.22 Cr. | ||||||||||||||||||||||||||||||||||||||||
ROE | 106% | 53.78% | ||||||||||||||||||||||||||||||||||||||||
ROCE | 47.07% | 57.29% | ||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.29 | |||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.95 | ₹2.85 | ||||||||||||||||||||||||||||||||||||||||
RoNW | 69.28% | 53.78% |
In the Satol Chemicals IPO Retail Individual Investors (RII) are offered while in Studio LSD IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Satol Chemicals IPO and 1,32,000 shares in Studio LSD IPO.
Satol Chemicals IPO | Studio LSD IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 2,11,200 shares | 6,88,000 shares |
QIB | 1,32,000 shares | |
NII | 51,72,000 shares | |
RII | 77,58,000 shares | |
Employee | 0 shares | |
Others | ||
Total | 1,30,62,000 shares |
Satol Chemicals IPO subscribed in total, whereas Studio LSD IPO subscribed 3.23x.
Satol Chemicals IPO | Studio LSD IPO | |
---|---|---|
QIB (times) | 1.00x | |
NII (times) | 1.25x | |
Big NII (times) | 0.96x | |
Small NII (times) | 1.84x | |
RII (times) | 4.58x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 3.23x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O